Peptonic Medical AB outlines short term strategic priorities to accelerate sales growth under the leadership of its new CEO
Peptonic Medical AB (“Peptonic”) clarifies short term strategic priorities under the leadership of its new CEO. Committed to achieving tangible results, the company is prioritizing its core product portfolio and streamlining organizational efforts to propel existing products and partner agreements. Challenges hindering this focus will be resolutely addressed or temporarily set aside. The impetus behind these strategic priorities is rooted in the recognition of substantial sales opportunities within the realm of existing products and partner markets.By concentrating efforts on maximizing